Tonix pharmaceuticals holding corp. (TNXP)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-7,273

-8,707

-7,838

-5,840

-6,233

-7,588

-5,479

-6,087

-6,935

-5,493

-5,786

-4,780

-5,064

-7,482

-7,578

-9,806

-13,976

-13,360

-13,250

-11,763

-9,681

-8,989

-7,419

-6,044

-5,164

-3,707

-3,090

-2,086

-2,001

-2,629

-1,732

-3,073

-2,014

-1,586

-1,014

-355

-513

Depreciation and amortization

6

5

5

7

9

11

13

15

15

20

16

10

24

-

-

-

57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

21

6

5

4

5

4

4

4

3

4

3

2

2

2

2

2

Amortization and write off of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-0

0

0

196

53

0

0

0

Non cash interest, consisting of beneficial conversion feature in connection with convertible debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

710

-426

0

426

-

-

-

-

Non cash interest, consisting of common stock and warrants issued in connection with convertible debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-0

344

0

81

0

0

0

0

Non-cash financing costs related to January and March 2012 financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-0

81

0

0

0

0

0

0

Warrants issued for services rendered

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21

6

13

11

0

0

0

0

-

-

-

-

Stock-based compensation

360

359

362

431

305

368

451

409

399

313

433

477

567

899

744

727

896

1,005

862

1,174

1,348

1,000

884

651

553

441

442

442

392

293

342

228

0

296

45

53

40

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-1,224

47

-

-

-

0

Common stock issued in exchange for intellectual property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

608

0

0

0

0

0

0

0

0

0

0

-8

8

Gain on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Changes in operating assets and liabilities:
Prepaid expenses and other

39

-

-479

-713

1,700

-

-295

-37

481

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

51

-234

121

-10

-1,503

63

-752

-178

1,234

565

-228

953

155

-239

381

126

382

0

-22

-156

181

-31

10

-38

99

-3

-15

-1

Deferred rent payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9

-

1

-1

-2

9

47

1

-2

-3

-1

-2

-1

-1

-0

-0

-0

-0

0

0

9

Accounts payable

-1,662

1,948

73

-88

-270

355

-591

374

-32

914

-797

338

-31

-71

-997

-131

-986

635

-337

783

502

-960

934

119

635

-220

-476

592

44

129

210

304

-512

-162

387

74

77

Lease liabilities and ROU asset, net

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-3

3

0

0

-35

38

0

0

0

Accrued expenses and other current liabilities

-716

848

305

62

-753

-40

420

-233

263

349

-120

-290

-300

-466

-548

398

-1,645

926

919

318

-289

856

450

-5

-572

314

252

254

36

166

-156

194

88

-8

16

-12

-7

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,995

-15,485

-11,912

-12,325

-9,238

-9,053

-8,218

-4,859

-5,699

-4,064

-3,531

-2,863

-761

-1,362

-

-

-

-

-

-

-

-

Net cash used in operating activities

-9,326

-6,714

-6,614

-4,713

-8,642

-6,824

-4,891

-5,485

-6,771

-4,927

-5,047

-4,360

-4,794

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,300

-1,129

-1,777

-1,466

-558

-231

-380

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of furniture and fixtures

-

5

2

3

7

-1

3

2

2

3

0

2

0

0

0

1

65

50

35

33

0

125

159

33

2

7

8

0

0

0

1

33

0

0

0

0

2

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

0

0

2,480

4,694

3,900

5,197

2,735

4,783

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in cash overdraft

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

Payment of restricted cash and interest earned on restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-0

0

0

0

0

0

0

0

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,734

4,718

-1,925

-22,093

-153

0

-125

-160

-105

-2

-7

-8

0

0

-

-

-

-

-

-

-

-

Net cash used by investing activities

-

-5

-2

-3

-7

1

-3

-2

-2

-3

0

2,478

4,694

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

-33

-0

-0

0

-14

14

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from demand notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Proceeds from other notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

320

0

0

0

500

0

0

0

Proceeds from related party promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

80

200

0

-

-

-

-

-

-

-

-

Proceeds from the exercise of warrants

7,474

0

0

0

70

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

303

469

131

4,758

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds, net of expenses of $711 and $0, from the sale of preferred stock

4,602

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Proceeds, net of expenses of $24 as of December 31, 2011 from Convertible Debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

390

0

0

0

1,001

500

0

0

Repayment of Convertible Debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

150

-

-

-

-

Proceeds, net of expenses of $1,352 (2013) and $506 (2012), from sale of units consisting of common stock and warrants, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Proceeds, net of expenses of $1,513 and $0, from sale of common stock and warrants

16,681

965

4,484

417

3

6,362

2,890

2,930

532

1,118

1

16,284

1,102

4,857

3,858

11,783

0

0

18,685

-54

29,054

0

7,182

0

40,654

0

10,042

0

0

2,545

0

-0

4,387

0

0

0

0

Net cash provided by financing activities

28,757

7,945

4,484

417

73

17,187

2,890

2,930

532

1,118

1

16,298

1,102

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-0

4,237

1,501

544

265

302

Effect of currency rate change on cash

-15

-

-

-

-10

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the sale of capital stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

44

265

302

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,783

0

0

18,694

-54

29,054

303

7,371

131

45,412

4,321

10,223

406

0

-

-

-

-

-

-

-

-

Effect of currency rate change on cash

-

-

-

-

-

-

-

-17

-2

-2

1

-4

0

-18

-1

-11

19

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash, cash equivalents and restricted cash

19,416

1,225

-2,126

-4,298

-8,586

10,361

-1,995

-2,574

-6,243

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of currency rate change on cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

-3

5

-4

-1

-1

0

0

0

-

-

-

-

-

-

-

-

Net (decrease) increase in cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-5,045

14,412

1,002

3,254

706

6,511

-10,748

-13,834

-15,728

-9,444

19,997

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41,345

-

7,352

-355

-1,362

1,749

-1,302

-1,163

2,460

34

-14

18

-62

Supplemental disclosures of cash flow information:
Issuance of common stock under employee benefit plan

-

-

-

-

-

-

-

-

-

-

64

0

10

0

54

0

113

0

90

0

70

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Senior convertible notes exchanged for preferred shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Capital contribution of accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

-

-

-

Demand notes together with accrued interest converted into capital stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

-

-

-

Common stock issued for deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

144

0

0

0

Exchange of Notes Payable for Convertible Debenture

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

320

0

0

0

-

-

-

-

Warrants Liability reclassified to Stockholders' Equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,938

0

-

-

-

-

Exchange of Convertible Debenture for Units consisting of common stock and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

710

0

1,925

0

-

-

-

-

Warrants issued in connection with January and March 2012 Financing charged to stockholders' deficiency

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3

-0

0

0

35

-

-

-

-

Non-cash financing activities:
Preferred stock deemed dividend

1,260

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant deemed dividend

451

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-